Venture Capital/AI, health, fintech, defense
General Catalyst (India) logo

General Catalyst (India)

Seed to growth fund research profile

General Catalyst combines seed-to-growth venture investing with company creation and strategic investments. Its India platform was formed around the Venture Highway merger and now focuses on AI, healthcare, defence technology, fintech and consumer technology.

At a glance

Founded
2000
Footprint
US / Bengaluru
Stage
Seed to growth, multi-stage

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

General Catalyst (India) uses a seed to growth, multi-stage approach across AI, health, fintech, defense.

Current evidence

$5B India commitment announced by General Catalyst for seed-through-growth investing, company creation and strategic investments.

Strategy

Seed to growth, multi-stage

Sector focus

AI, health, fintech, defense

AIF structure context

Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.

Current signal

$5B India commitment announced by General Catalyst for seed-through-growth investing, company creation and strategic investments.

Investor questions

General Catalyst (India) research questions

What is General Catalyst (India)'s investment strategy?

General Catalyst (India) is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Seed to growth, multi-stage, with a sector focus of AI, health, fintech, defense. The profile should be read with the linked source trail and Typical route: Category I AIF context.

What portfolio evidence is available for General Catalyst (India)?

The profile displays only company or asset names attributable to General Catalyst (India) in the reviewed public sources: Zepto, PB Health, Raphe, Jeh Aerospace, Pronto, Ayr Energy, CRED, Spinny, Orange Health, CityMall, StockGro. It does not represent a complete current portfolio unless the manager has published one.

What is known about General Catalyst (India)'s performance or track record?

The manager has disclosed a $5B India commitment over five years and a seed-to-growth mandate. Public reporting identifies Indian positions including Zepto, CRED, Spinny, PB Health and Orange Health; the public record does not disclose a single India fund-level return figure. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are General Catalyst (India)'s fund size, fees and minimum investment?

Public fund size: $5B India commitment over five years announced in February 2026; global Fund XII was reported at $8B in 2024.. Public terms or access information: Seed through growth, company creation and strategic investments; India-specific cheque sizes and carry terms are not disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on General Catalyst (India)'s investment team?

The current source record names Hemant Taneja; Neeraj Arora (India). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with General Catalyst (India)?

Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Deployment pace vs pledge; India team depth.

What is the latest public update on General Catalyst (India)?

2026-02-23: $5B India commitment announced by General Catalyst for seed-through-growth investing, company creation and strategic investments.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →